Intravenous Thrombolysis in Patients With Recent Intake of Direct Oral Anticoagulants: A Target Trial Analysis and Comparison With Reversal Agent Use.
Meinel TR, Bücke P, D'Anna L, Merlino G, Aguiar de Sousa D, Poli S, Purrucker JC, Strambo D, Romoli M, De Marchis GM, Pfeilschifter W, Zedde M, Marto JP, Candelaresi P, Lemmens R, Scoppettuolo P, Woock M, Kermer P, Kristoffersen ES, Ghannam M, Frol S, Nolte CH, Yakushiji Y, Touzé E, Uphaus T, Mannino M, Ntaios G, Padjen V, Henninger N, Zipser-Mohammadzada F, Mariano ME, Guerreiro C, Burini A, Ceccarelli L, Valente M, Gomez-Exposito A, Kleeberg A, Thevoz G, Michel P, Stufano G, Vlachos D, Herrmann M, Rodrigues B, Spina E, Andreone V, Allardt A, Alshaer QN, Riegler C, Kunieda T, Boulanger M, Hahn M, Papadimitriou D, Muppa J, Maes L, Ranta A, Tyson A, Barber PA, Davis A, Wu TY, Kaesmacher J, Fischer U, Seiffge DJ; International DO-IT Collaboration.
Meinel TR, et al.
Stroke. 2025 Jul 22. doi: 10.1161/STROKEAHA.125.051384. Online ahead of print.
Stroke. 2025.
PMID: 40693390